BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35378006)

  • 1. Mechanistic Episodes on SARS-CoV-2-Mediated Neurological Manifestations and Their Possible Therapeutic Interventions.
    Nida S; Srinivisan H; Pandurangan AK; Waseem M
    J Environ Pathol Toxicol Oncol; 2022; 41(1):85-98. PubMed ID: 35378006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis.
    Ganesh A; Reis IR; Varma M; Patry DG; Cooke LJ
    Can J Neurol Sci; 2022 Jul; 49(4):514-531. PubMed ID: 34287109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of COVID-19 and neurological complications.
    Hosseini N; Nadjafi S; Ashtary B
    Rev Neurosci; 2021 Aug; 32(6):671-691. PubMed ID: 33583157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
    Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
    Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Neurologic Manifestations of Respiratory Viruses.
    Pizzi MA
    Continuum (Minneap Minn); 2021 Oct; 27(5):1365-1381. PubMed ID: 34618764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance Study of Acute Neurological Manifestations among 439 Egyptian Patients with COVID-19 in Assiut and Aswan University Hospitals.
    Khedr EM; Abo-Elfetoh N; Deaf E; Hassan HM; Amin MT; Soliman RK; Attia AA; Zarzour AA; Zain M; Mohamed-Hussein A; Hashem MK; Hassany SM; Aly A; Shoyb A; Saber M
    Neuroepidemiology; 2021; 55(2):109-118. PubMed ID: 33631765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Observational Study of Neurological Manifestations in COVID-19 (SON-CoV).
    Ramrakhiani N; Bhutani N; Chaudhary D; Parab P; Singh K; Agrawal P; Gupta V
    J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct and indirect neurological manifestations of COVID-19].
    Gromova OA; Torshin IY; Semenov VA; Putilina MV; Chuchalin AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):11-21. PubMed ID: 33340292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological symptoms as a clinical manifestation of coronavirus disease 2019: implications for internists.
    Adamczyk-Sowa M; Niedziela N; Kubicka-Bączyk K; Wierzbicki K; Jaroszewicz J; Sowa P
    Pol Arch Intern Med; 2021 Jan; 131(1):54-62. PubMed ID: 32820884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.